1. Home
  2. Author
  3. Massoud F

Massoud F

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (9)

Title : CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia - Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
Author(s) : Herrmann N , Ismail Z , Collins R , Desmarais P , Goodarzi Z , Henri-Bhargava A , Iaboni A , Kirkham J , Massoud F , Moser A , Silvius J , Watt J , Seitz D
Ref : Alzheimers Dement (N Y) , 8 :e12099 , 2022
Abstract : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
ESTHER : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
PubMedSearch : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099
PubMedID: 35128025

Title : Cholinesterase inhibitors in vascular cognitive impairment -
Author(s) : Massoud F
Ref : Can Journal of Neurology Sci , 40 :446 , 2013
PubMedID: 23786722

Title : Persistence with cholinesterase inhibitor treatment in Alzheimer's disease -
Author(s) : Massoud F
Ref : Can Journal of Neurology Sci , 40 :623 , 2013
PubMedID: 23968931

Title : Pharmacological treatment of Alzheimer disease - Massoud_2011_Can.J.Psychiatry_56_579
Author(s) : Massoud F , Leger GC
Ref : Can J Psychiatry , 56 :579 , 2011
Abstract : Massoud_2011_Can.J.Psychiatry_56_579
ESTHER : Massoud_2011_Can.J.Psychiatry_56_579
PubMedSearch : Massoud_2011_Can.J.Psychiatry_56_579
PubMedID: 22014690

Title : Switching cholinesterase inhibitors in older adults with dementia - Massoud_2011_Int.Psychogeriatr_23_372
Author(s) : Massoud F , Desmarais JE , Gauthier S
Ref : Int Psychogeriatr , 23 :372 , 2011
Abstract : Massoud_2011_Int.Psychogeriatr_23_372
ESTHER : Massoud_2011_Int.Psychogeriatr_23_372
PubMedSearch : Massoud_2011_Int.Psychogeriatr_23_372
PubMedID: 21044399

Title : Care of dementia in Canada: a collaborative care approach with a central role for the primary care physician -
Author(s) : Massoud F , Lysy P , Bergman H
Ref : J Nutr Health Aging , 14 :105 , 2010
PubMedID: 20126957

Title : Update on the pharmacological treatment of Alzheimer's disease - Massoud_2010_Curr.Neuropharmacol_8_69
Author(s) : Massoud F , Gauthier S
Ref : Curr Neuropharmacol , 8 :69 , 2010
Abstract : Massoud_2010_Curr.Neuropharmacol_8_69
ESTHER : Massoud_2010_Curr.Neuropharmacol_8_69
PubMedSearch : Massoud_2010_Curr.Neuropharmacol_8_69
PubMedID: 20808547

Title : Drug utilization review of cholinesterase inhibitors in Quebec -
Author(s) : Massoud F , Dorais M , Charbonneau C , Lescrauwaet B , Boucher JM , LeLorier J
Ref : Can Journal of Neurology Sci , 35 :508 , 2008
PubMedID: 18973072

Title : A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes - Charbonneau_2008_Curr.Med.Res.Opin_24_3287
Author(s) : Charbonneau C , Massoud F , Dorais M , LeLorier J
Ref : Curr Med Res Opin , 24 :3287 , 2008
Abstract : Charbonneau_2008_Curr.Med.Res.Opin_24_3287
ESTHER : Charbonneau_2008_Curr.Med.Res.Opin_24_3287
PubMedSearch : Charbonneau_2008_Curr.Med.Res.Opin_24_3287
PubMedID: 19032117